Page last updated: 2024-12-05

4-methylglutamic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-methylglutamic acid : A glutamic acid derivative that is glutamic acid substituted by a methyl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5365
CHEMBL ID38241
CHEBI ID176455
SCHEMBL ID1060785
MeSH IDM0133751

Synonyms (22)

Synonym
CHEBI:176455
2-amino-4-methylpentanedioic acid
nsc-41355
NSC41355 ,
NCI60_003938
59685-03-9
nsc-16564
nsc16564
2-amino-4-methyl-pentanedioic acid
4-methylglutamic acid
14561-55-8
4 methylglutamic acid
CHEMBL38241
FT-0671799
FT-0604674
SCHEMBL1060785
4-methylglutamic acid #
dl-4-methyl-dl-glutamic acid
KRKRAOXTGDJWNI-UHFFFAOYSA-N
4-methyl-dl-glutamic acid
(2s,4s)-4-methylglutamicacid
DTXSID20932652

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" However, it is unclear whether the kainate receptor itself mediates any of the toxic responses."( Cytotoxic effects of kainate ligands on HEK cell lines expressing recombinant kainate receptors.
Carver, JM; Cortes-Burgos, L; Giordano, T; Howe, JR; Mansson, PE; Shu, J; Zhou, LM, 1996
)
0.29
" The toxic effect of kainate may be associated with calcium influx, because toxicity was reduced by polyamines that suppress calcium influx and by an inhibitor of calcium phosphatase."( A non-excitatory paradigm of glutamate toxicity.
Shen, W; Slaughter, MM, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
glutamic acid derivativeAn amino acid derivative resulting from reaction of glutamic acid at the amino group or either of the carboxy groups, or from the replacement of any hydrogen by a heteroatom. The definition normally excludes peptides containing glutamic acid residues.
amino dicarboxylic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID108506Ratio between EC50 of compound and glutamate measured against metabotropic glutamate receptor 11999Journal of medicinal chemistry, May-06, Volume: 42, Issue:9
Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation.
AID108985Ratio between EC50 of compound and glutamate measured against Metabotropic glutamate receptor 21999Journal of medicinal chemistry, May-06, Volume: 42, Issue:9
Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation.
AID493017Wombat Data for BeliefDocking2009ChemMedChem, Jan, Volume: 4, Issue:1
Stereocontrolled synthesis and pharmacological evaluation of azetidine-2,3-dicarboxylic acids at NMDA receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.17)18.7374
1990's17 (36.96)18.2507
2000's23 (50.00)29.6817
2010's5 (10.87)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.91 (24.57)
Research Supply Index3.91 (2.92)
Research Growth Index5.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other49 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]